Trial · NCT03319563
Registered outcomes28
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 28
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Estimated blood loss | Intraoperative | milliliter |
| Primary | Total Morphine consumption. | during first 24 hours postoperatively. | milligram |
| Secondary | The surgical field visualization for subcutaneous incision | Intraoperative, 10 minutes after skin incision. | measured by Fromme's operative visibility scale (0-5) ,5: Massive uncontrollable bleeding, Surgery impossible. 4: Heavy but controllable. 3: Moderate bleeding , 2: Moderate bleeding but without interference with accurate dissection. 1: Bleeding, so mild, No suctioning. 0: No bleeding, |
| Secondary | The surgical field visualization for muscular dissection | Intraoperative, 30 minutes after the thoracolumbar fascia incision, | measured by Fromme's operative visibility scale (0-5) ,5: Massive uncontrollable bleeding, Surgery impossible. 4: Heavy but controllable. 3: Moderate bleeding , 2: Moderate bleeding but without interference with accurate dissection. 1: Bleeding, so mild, No suctioning. 0: No bleeding, |
| Secondary | The surgical field visualization for nails insertion | Intraoperative, 30 minutes after the first nail insertion. | measured by Fromme's operative visibility scale (0-5) ,5: Massive uncontrollable bleeding, Surgery impossible. 4: Heavy but controllable. 3: Moderate bleeding , 2: Moderate bleeding but without interference with accurate dissection. 1: Bleeding, so mild, No suctioning. 0: No bleeding, |
| Secondary | The surgical field visualization for osteotomy | Intraoperative, 20 minutes after the first osteotomy | measured by Fromme's operative visibility scale (0-5) ,5: Massive uncontrollable bleeding, Surgery impossible. 4: Heavy but controllable. 3: Moderate bleeding , 2: Moderate bleeding but without interference with accurate dissection. 1: Bleeding, so mild, No suctioning. 0: No bleeding, |
| Secondary | The operative duration | Intraoperative | minutes, from the start of anesthesia induction to extubation times |
| Secondary | The number of blood transfusion unites. | intraoperative | unites of packed red blood cells |
| Secondary | Nitroglycerin consumption | Intraoperative | milligram |
| Secondary | Fentanyl consumption | intraoperative | microgram |
| Secondary | Atracurium consumption | intraoperative | milligram |
| Secondary | Propranolol consumption | intraoperative | milligram |
| Secondary | Mean blood pressure (MBP) | basal, 5 minutes after the onsite of infiltration, 3 minutes after the onsite of skin incision, then after 30, 60, 90, 120, 150, 180, 210, 240, 270, 300 minutes from the start of anesthesia. | millimeter mercury |
| Secondary | Mean heart rate (HR) | basal, 5 minutes after the onsite of infiltration, 3 minutes after the onsite of skin incision, then after 30, 60, 90, 120, 150, 180, 210, 240, 270, 300 minutes from the start of anesthesia. | beats per minute |
| Secondary | Inhalational isoflurane concentration | intraoperative: at 30, 60, 90, 120, 150, 180, 210, 240, 270, 300 minutes from the start of anesthesia induction. | percent |
| Secondary | The number of hypertensive episodes | intraoperative | defined as more than 25% rise of MBP than the basal, provided as total number |
| Secondary | The number of tachycardic episodes | intraoperative | defined as more than 25% rise of HR than the basal, provided as total number |
| Secondary | Ephedrine consumption | intraoperative | milligram |
| Secondary | The total amount of fluid utilization. | intraoperative | milliliter |
| Secondary | Visual analog score | postoperative at 1,4,8,12,16, 20, 24 hours | scale (0-10), 0= no pain |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03319563/registered